Nevertheless, reduced levels of PEDF and consequently reduced inhibition of angiogenesis could serve as a marker for neovascularization but elevated levels fail to be classified as a diagnostic or progression marker for glaucoma in particular. Here, SERPINF1 is linked to glaucoma.